Search…

Shanghai Pharmaceuticals (02607): The ANDA for Aciclovir Tablet Approved by US FDA for Marketing.

10/11/2025

China Fortune Financial APP news, Shanghai Pharmaceuticals (02607) announced that Shanghai Pharmaceuticals Group Co., Ltd. subsidiary Shanghai Pharmaceuticals Traditional Chinese and Western Medicine Co., Ltd. (Shanghai Traditional Chinese and Western Medicine) has received a notification from the Food and Drug Administration (FDA) of the United States recently. its Abbreviated New Drug Application (ANDA) for Acetazolamide tablets has been finally approved for listing.

Latest

3 m ago

The Stoxx Europe 600 index widened its gains to 1.5%, reaching an intraday high.

4 m ago

Chinese New Retail Supply Chain (03928) plans to sell Singapore property.

5 m ago

According to AI Express, Huayuan Securities released a research report on November 10, giving Jinbo Biotech (920982.SH) a "buy" rating. The main reasons for the rating include: 1) the company's injection-type A-type recombinant human collagen protein products as the basic plate, functional skincare products bring additional volume; 2) the company actively responds to the demand of China's health industry, and its private placement has been accepted by the stock exchange. (Daily Economic News)

5 m ago

According to every AI fast news, Huayuan Securities released a research report on November 10th, giving Kang Crown Technology (001308.SZ) a "buy" rating. The rating reasons mainly include: 1) Kang Crown Technology announced its third quarter report for 2025; 2) Innovative display business has high growth, significant adjustment in business structure; 3) Actively deploying in-vehicle business, strengthening diversified product matrix. (Daily Economic News)

5 m ago

China Everbright Water Limited (01857): China Everbright Water was awarded two authoritative certifications in Singapore's capital market.

See all latest